Yafarm Technologies (YFRM) 0.0023 $YFRM
Integrative Stem Cell Holdings Changes Name and Effects Reverse Split
PR Newswire - Wed Jul 30, 2:30PM CDT
Integrative Stem Cell Holdings, Inc., a corporation formerly known as YaFarm Technologies, Inc. (OTC: YFRM) (OTC Pink: YFRM), announced today that it has filed an Amended and Restated Certificate of Incorporation with the Secretary of State of Delaware which changes the company's name to "Profile Solutions, Inc." and effects a 1:10 reverse stock split of its outstanding common stock, among other actions. The effective date of the name change and split will be July 31, 2014. Our new CUSIP number for our common stock will be 74317L106. Our common stock will be quoted under the symbol "YFRMD" for 20 business days and then it will change to our new stock symbol of "PSIQ." These actions were taken following the recent acquisition of Profile Solutions, Inc., a Florida corporation, by Integrative Stem Cell Holdings. This transaction, which closed in May 2014, resulted in a change of control of our company and was treated as a reverse merger for accounting purposes. Our business and operations are now those of Profile Solutions. At closing, Mr. Dore Scott Perler was appointed our sole director and elected our Chief Executive Officer. Mr. Perler is also the majority stockholder of our company.
YFRM Technologies, Inc. Completes Acquisition of the Integrative Stem Cell Institute
M2 - Tue May 21, 8:38AM CDT
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm) is pleased to announce the completion of its acquisition of the Integrative Stem Cell Institute (the ISCI). The new company, to be called "the Integrative Stem Cell Institute," will continue the pioneering work of the ISCI in the field of cell-based regenerative medicine. The ISCI will be housed in Cancun's Hospital Galenia and will combine a world-class medical facility with a state-of-the-art laboratory in the investigational treatments of patients with chronic and degenerative diseases as part of controlled clinical studies.
Tuesday's Market Alerts for: YFRM, JASO, NVLX, ACTC
ACCESSWIRE - Tue May 21, 7:46AM CDT
CORAL SPRINGS, FL - "Active Companies to Watch" for today: YaFarm Technologies, Inc. (OTC: YFRM), JA Solar Holdings Co., Ltd. (NASDAQ: JASO), Nuvilex, Inc. (OTCQB: NVLX), Advanced Cell Technology, Inc. (OTCQB: ACTC)
YaFarm Technologies, Inc. Announces ISCI Grand Opening
Marketwire - Wed Mar 27, 6:30AM CDT
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) is pleased to announce the grand opening of The Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies. The Institute is located within Hospital Galenia at 77505 Benito Juarez Quintana Roo, Mexico and the telephone number is 1.503.446.5039 (US).
YaFarm Technologies Announces Funding for ISCI
Marketwire - Wed Mar 06, 6:30AM CST
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) announced today that the Integrative Stem Cell Institute (ISCI) has received significant funding for its venture in Cancun, Mexico.
YaFarm Technologies Updates on World Class Lab in ISCI Stem Cell Center
Marketwire - Tue Mar 05, 6:25AM CST
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) announced today that the Integrative Stem Cell Institute (ISCI) has made significant progress on the construction of its World Class Lab in the ISCI Stem Cell Center in Cancun, Mexico. On February 8, 2013 YaFarm Technologies, Inc. announced that the Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies, had initiated design and development of a new, world-class cell processing and culture laboratory in Cancun, Mexico. The ISCI is pleased to inform shareholders that progress on the class 10,000, ISO 7 clean room for the processing of autologous, mesenchymal cells for point-of-care therapies is ahead of schedule.
YaFarm Technologies Announces ISCI Release of Patient Publications
Marketwire - Mon Mar 04, 6:32AM CST
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) is pleased to announce the Integrative Stem Cell Institute (ISCI) has released three proprietary documents for patients seeking stem cell based therapies. These documents concerning stem cell procedures will be available to both new and existing patients.
YaFarm Technologies Announces ISCI Clinical Study
Marketwire - Mon Feb 25, 6:37AM CST
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) announced today that the Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies, has initiated its first clinical study in Degenerative Neuromuscular Diseases (DNMD).
ISCI Announces Medical & Laboratory Director
Marketwire - Thu Feb 21, 6:30AM CST
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) announced today that The Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies, has announced the appointment of Dr Eduardo Cervera Ceballos, MD as its Medical and Laboratory Director.
YaFarm Technologies, Inc. Recaps Major Developments
M2 - Tue Feb 19, 8:03AM CST
PITTSTON, ME, Feb 19, 2013 -- YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) has reached several important milestones since signing the definitive agreement with The Integrative Stem Cell Institute (ISCI). YaFarm has appointed top level management for ISCI by announcing David Audley as CEO and Juan A. Castillo as Chairman of the Board of Directors. Dr. Castillo is a pioneer in regenerative medicine and has successfully treated over 250 patients using adult stem cells, while Mr. Audley successfully managed the International Cellular Medicine Society (ICMS) for nearly 4 years. Under Mr. Audley's leadership, the organization grew from 7 physicians to over 3500 members from 35 countries.
YaFarm Technologies Announces ISCI IRB Submission
Marketwire - Fri Feb 15, 6:30AM CST
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) is pleased to announce that The Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies, has submitted its complete protocols for the treatment of chronic and degenerative diseases to the Institutional Review Board (IRB) of the International Cell Surgical Society (ICSS).
ISCI Announces Global Physician Network
M2 - Wed Feb 13, 8:35AM CST
PITTSTON, ME, Feb 12, 2013 -- YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) announced today that The Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies, has launched a global physician's network, to connect international patients to local physicians, and to link physicians to opportunities for education, training and collaboration in regenerative medicine.
YaFarm Technologies Taps Esteemed Industry Professionals for Leadership Roles at the ISCI
M2 - Mon Feb 11, 8:26AM CST
PITTSTON, ME, Feb 11, 2013 -- YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) announced today the appointment of top level management for the Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies. YaFarm announced that David Audley has been appointed CEO of the ISCI, while Juan A. Castillo has been elected Chairman of the Board of Directors. YaFarm expects to announce members of its Board of Directors and Advisory Board in the near future.
YaFarm Technologies Announces World Class Lab in ISCI Stem Cell Center
M2 - Fri Feb 08, 8:39AM CST
PITTSTON, ME, Feb 08, 2013 -- YaFarm Technologies, Inc. (OTC Pink: YFRM) (YaFarm, or the Company) announced today that the Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell- based therapies, is initiating design and development of a new, world-class cell processing and culture laboratory in Cancun, Mexico.
OTC Stock Review Issues a Report on YaFarm Technologies, Inc.
GlobeNewswire - Thu Feb 07, 7:12AM CST
OTC Stock Review announces that it has published a report on YaFarm Technologies (OTC:YFRM). YaFarm Technologies, Inc. recently signed a definitive agreement to acquire the Integrative Stem Cell Institute (the ISCI), located at the Galenia Hospital of Cancun, which is one of the pioneers in the field of cell-based regenerative medicine. ISCI's facilities include a Good Processing Practice laboratory with a clean room and fully equipped with state-of-the-art equipment. ISCI's facility was specifically designed to safely process cellular materials for clinical studies and therapeutic use. It can also be used to safely preserve cells for later applications.
Integrative Stem Cell Holdings Changes Name and Effects Reverse Split
PR Newswire - Wed Jul 30, 2:30PM CDT
Integrative Stem Cell Holdings, Inc., a corporation formerly known as YaFarm Technologies, Inc. (OTC: YFRM) (OTC Pink: YFRM), announced today that it has filed an Amended and Restated Certificate of Incorporation with the Secretary of State of Delaware which changes the company's name to "Profile Solutions, Inc." and effects a 1:10 reverse stock split of its outstanding common stock, among other actions. The effective date of the name change and split will be July 31, 2014. Our new CUSIP number for our common stock will be 74317L106. Our common stock will be quoted under the symbol "YFRMD" for 20 business days and then it will change to our new stock symbol of "PSIQ." These actions were taken following the recent acquisition of Profile Solutions, Inc., a Florida corporation, by Integrative Stem Cell Holdings. This transaction, which closed in May 2014, resulted in a change of control of our company and was treated as a reverse merger for accounting purposes. Our business and operations are now those of Profile Solutions. At closing, Mr. Dore Scott Perler was appointed our sole director and elected our Chief Executive Officer. Mr. Perler is also the majority stockholder of our company.
YFRM Technologies, Inc. Completes Acquisition of the Integrative Stem Cell Institute
M2 - Tue May 21, 8:38AM CDT
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm) is pleased to announce the completion of its acquisition of the Integrative Stem Cell Institute (the ISCI). The new company, to be called "the Integrative Stem Cell Institute," will continue the pioneering work of the ISCI in the field of cell-based regenerative medicine. The ISCI will be housed in Cancun's Hospital Galenia and will combine a world-class medical facility with a state-of-the-art laboratory in the investigational treatments of patients with chronic and degenerative diseases as part of controlled clinical studies.
Tuesday's Market Alerts for: YFRM, JASO, NVLX, ACTC
ACCESSWIRE - Tue May 21, 7:46AM CDT
CORAL SPRINGS, FL - "Active Companies to Watch" for today: YaFarm Technologies, Inc. (OTC: YFRM), JA Solar Holdings Co., Ltd. (NASDAQ: JASO), Nuvilex, Inc. (OTCQB: NVLX), Advanced Cell Technology, Inc. (OTCQB: ACTC)
YaFarm Technologies, Inc. Announces ISCI Grand Opening
Marketwire - Wed Mar 27, 6:30AM CDT
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) is pleased to announce the grand opening of The Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies. The Institute is located within Hospital Galenia at 77505 Benito Juarez Quintana Roo, Mexico and the telephone number is 1.503.446.5039 (US).
YaFarm Technologies Announces Funding for ISCI
Marketwire - Wed Mar 06, 6:30AM CST
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) announced today that the Integrative Stem Cell Institute (ISCI) has received significant funding for its venture in Cancun, Mexico.
YaFarm Technologies Updates on World Class Lab in ISCI Stem Cell Center
Marketwire - Tue Mar 05, 6:25AM CST
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) announced today that the Integrative Stem Cell Institute (ISCI) has made significant progress on the construction of its World Class Lab in the ISCI Stem Cell Center in Cancun, Mexico. On February 8, 2013 YaFarm Technologies, Inc. announced that the Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies, had initiated design and development of a new, world-class cell processing and culture laboratory in Cancun, Mexico. The ISCI is pleased to inform shareholders that progress on the class 10,000, ISO 7 clean room for the processing of autologous, mesenchymal cells for point-of-care therapies is ahead of schedule.
YaFarm Technologies Announces ISCI Release of Patient Publications
Marketwire - Mon Mar 04, 6:32AM CST
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) is pleased to announce the Integrative Stem Cell Institute (ISCI) has released three proprietary documents for patients seeking stem cell based therapies. These documents concerning stem cell procedures will be available to both new and existing patients.
YaFarm Technologies Announces ISCI Clinical Study
Marketwire - Mon Feb 25, 6:37AM CST
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) announced today that the Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies, has initiated its first clinical study in Degenerative Neuromuscular Diseases (DNMD).
ISCI Announces Medical & Laboratory Director
Marketwire - Thu Feb 21, 6:30AM CST
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) announced today that The Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies, has announced the appointment of Dr Eduardo Cervera Ceballos, MD as its Medical and Laboratory Director.
YaFarm Technologies, Inc. Recaps Major Developments
M2 - Tue Feb 19, 8:03AM CST
PITTSTON, ME, Feb 19, 2013 -- YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) has reached several important milestones since signing the definitive agreement with The Integrative Stem Cell Institute (ISCI). YaFarm has appointed top level management for ISCI by announcing David Audley as CEO and Juan A. Castillo as Chairman of the Board of Directors. Dr. Castillo is a pioneer in regenerative medicine and has successfully treated over 250 patients using adult stem cells, while Mr. Audley successfully managed the International Cellular Medicine Society (ICMS) for nearly 4 years. Under Mr. Audley's leadership, the organization grew from 7 physicians to over 3500 members from 35 countries.
YaFarm Technologies Announces ISCI IRB Submission
Marketwire - Fri Feb 15, 6:30AM CST
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) is pleased to announce that The Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies, has submitted its complete protocols for the treatment of chronic and degenerative diseases to the Institutional Review Board (IRB) of the International Cell Surgical Society (ICSS).
ISCI Announces Global Physician Network
M2 - Wed Feb 13, 8:35AM CST
PITTSTON, ME, Feb 12, 2013 -- YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) announced today that The Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies, has launched a global physician's network, to connect international patients to local physicians, and to link physicians to opportunities for education, training and collaboration in regenerative medicine.
YaFarm Technologies Taps Esteemed Industry Professionals for Leadership Roles at the ISCI
M2 - Mon Feb 11, 8:26AM CST
PITTSTON, ME, Feb 11, 2013 -- YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) announced today the appointment of top level management for the Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies. YaFarm announced that David Audley has been appointed CEO of the ISCI, while Juan A. Castillo has been elected Chairman of the Board of Directors. YaFarm expects to announce members of its Board of Directors and Advisory Board in the near future.
YaFarm Technologies Announces World Class Lab in ISCI Stem Cell Center
M2 - Fri Feb 08, 8:39AM CST
PITTSTON, ME, Feb 08, 2013 -- YaFarm Technologies, Inc. (OTC Pink: YFRM) (YaFarm, or the Company) announced today that the Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell- based therapies, is initiating design and development of a new, world-class cell processing and culture laboratory in Cancun, Mexico.
OTC Stock Review Issues a Report on YaFarm Technologies, Inc.
GlobeNewswire - Thu Feb 07, 7:12AM CST
OTC Stock Review announces that it has published a report on YaFarm Technologies (OTC:YFRM). YaFarm Technologies, Inc. recently signed a definitive agreement to acquire the Integrative Stem Cell Institute (the ISCI), located at the Galenia Hospital of Cancun, which is one of the pioneers in the field of cell-based regenerative medicine. ISCI's facilities include a Good Processing Practice laboratory with a clean room and fully equipped with state-of-the-art equipment. ISCI's facility was specifically designed to safely process cellular materials for clinical studies and therapeutic use. It can also be used to safely preserve cells for later applications.
